CANNABINOID COMBINATIONS FOR TREATING CHRONIC PAIN IN DIALYSIS PATIENTS

摘要

The present invention is directed to a cannabinoid combination comprising, as the only cannabinoids, cannabidiol (CBD) and A9-tetrahydrocannabinol (THC), or enantiomers, diastereomers, or racemates thereof, for use in the treatment of chronic pain and associated symptoms in a subject suffering from end-stage renal disease (ESRD) and treated with dialysis, or for improving the efficacy and/or reducing adverse effects of at least one analgesic used for treating pain in a subject suffering from ESRD and treated with dialysis, wherein the CBD:THC weight ratio in the cannabinoid combination is about of 4:1 to about 10:1, preferably about 6:1.